April 2008

Physicians' Financial News focuses on news-making and/or notable companies in the oncology biotechnology sector.

Topics covered in this issue include:1. Cost Effectiveness of Extended Letrozole Treatment After Discontinuation of Tamoxifen.

Clinical Trial Reports in this issue include:Phase IV:1) Long-Term Aspirin Therapy Reduces Colorectal Cancer RiskPhase III:1) Does Adding Cisplatin to Adjuvant Chemotherapy Improve Outcomes in Advanced Gastric Cancer?

Articles in this issue include:1) Germany: Drop the Syringe, Pick up the Tattooing Needle

News reports in this issue include: - Tentative Link Established Between Skin Cancer and Colon Cancer

Women whose breast cancer recurred after treatment had almosttwo times as much estrogen in their blood than did women whoremained cancer free--despite treatment with anti estrogen drugs in a majority of the women.

The 5th Annual Gastrointestinal (GI) Cancers Symposium was held in January in Orlando, Florida. Educational sessions and abstract presentations focused on each type of GI cancer, including cancers of the esophagus, stomach, hepatobiliary tree, pancreas, small bowel, colon, and rectum. Key presentations are summarized below.

In this issue our editors highlight the American Society of Clinical Oncology's 2008 Gastrointestinal Cancers Symposium held in January in Orlando, FL. As always, our departments provide a range of perspectives for the oncology professional--from Global Reports and Reimbursement and Managed Care to Clinical Trial Reports and Physicians' Financial News.